GAM
RMD icon

Groupama Asset Management’s ResMed RMD Stock Holding History

Groupama Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-941
Closed -$211K – 417
2026
Q1 		$211K Sell
941
-1,537
-62% -$383K ﹤0.01% 382
2025
Q4 		$597K Sell
2,478
-180
-7% -$46K 0.01% 316
2025
Q3 		$728K Sell
2,658
-2,834
-52% -$774K 0.01% 305
2025
Q2 		$1.4M Buy
5,492
+4,368
+389% +$1.04M 0.02% 235
2025
Q1 		$247K Buy
+1,124
New +$262K ﹤0.01% 380
2024
Q4 		– Sell
-3,514
Closed -$689K – 484
2024
Q3 		$689K Buy
3,514
+17
+0.5% +$3.8K 0.02% 305
2024
Q2 		$669K Sell
3,497
-1,748
-33% -$355K 0.01% 342
2024
Q1 		$2.16M Sell
5,245
-7,374
-58% -$1.35M 0.04% 221
2023
Q4 		$2.17M Buy
+12,619
New +$1.94M 0.06% 195

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Groupama Asset Management's RMD Position: Q2 2026 in Review

Groupama Asset Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 941 shares — an estimated $211K sold.

Groupama Asset Management first reported a position in RMD in Q4 2023 and held it in 9 quarters. The position peaked at $2.17M in Q4 2023. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Groupama Asset Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Groupama Asset Management sold 941 ResMed shares in Q2 2026, an estimated $211K.
  • Groupama Asset Management first reported a position in ResMed in Q4 2023 and held it in 9 quarters.
  • Groupama Asset Management's ResMed position peaked at $2.17M in Q4 2023.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.